Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Patients with inflammatory bowel disease on anti-TNFα therapy can develop temporary hair loss, but hair regrows fully with treatment changes.

Dupilumab can cause unexpected scalp issues, so early symptom recognition is important to avoid hair loss.

A patient with Crohn's disease grew back their hair after stopping Adalimumab, which had caused hair loss.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Intralesional cidofovir may be a viable treatment for conjunctival lesions in Melkersson-Rosenthal syndrome without systemic toxicity.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Diagnosing and treating rapidly worsening lung disease is difficult and requires better guidelines and understanding.

Systemic corticosteroids can cause unusual skin issues in people with juvenile rheumatoid arthritis.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

COVID-19 may trigger severe skin flare-ups in people with autoimmune conditions like lupus.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

High-dose corticosteroid treatment helped improve symptoms in a patient with Adult Onset Still Disease.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

Aggressive immunosuppressive treatment improved a woman's severe heart condition linked to autoimmune disease.

The child was diagnosed with a skin condition involving inflamed hair follicles.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

A 36-year-old man had unusual skin lesions on his face without hair loss.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Biologic therapies can cause various adverse events, but allergy/immunology clinicians can manage them.

Infliximab was effective in treating a scalp condition that did not respond to other treatments.

A woman with Rhupus and Rowell syndrome was treated successfully with medication adjustments.

Tislelizumab can cause cutaneous lupus erythematosus.

TNF-inhibitor induced alopecia can be treated effectively with different therapies.

Different rheumatological diseases can cause specific skin problems.

Dietary lipids affect inflammation and are crucial for normal cell function and immune health.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.